Vaxchora Side Effects, Safety, and Effectiveness




Vaxchora Side Effects. In June this year, the Food and Drug Administration (FDA) approved Vaxchora as a vaccine for cholera. To date, it is the only vaccine given the thumbs up by the agency for the prevention of cholera among adults aged 18 to 64 years old.

vaxchora side effects

What are some Vaxchora side effects? According to PaxVax, the Vaxchora drug maker, the following adverse health reactions to Vaxchora were noted during trials in the United States and Australia:

  • tiredness
  • headache
  • abdominal pain
  • nausea
  • vomiting
  • lack of appetite
  • diarrhea
  • fever

Please note that the above list is not exclusive.

If you experience side effects aside from the ones listed, you might want to report them to the FDA at 1-800-FDA-1088.

vaxchora side effects include abdominal pain

Abdominal pain is a possible side effect from Vaxchora use.

Can you use Vaxchora if you are using antibiotics? Apparently, not. In fact, the drugmaker advises doctors to “not administer Vaxchora to patients who have received oral or parenteral antibiotics within 14 days prior to vaccination”.

Meantime, here are other important guidelines for Vaxchora use among among pregnant women, children, and oldsters:

PREGNANT WOMEN. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Vaxchora during pregnancy. To enroll in or obtain information about the registry, please call PaxVax at 1-800-533-5899.



Risk Summary: Vaxchora is not absorbed systemically following oral administration, and maternal use is not
expected to result in fetal exposure to the drug.

Clinical Considerations: Disease-associated maternal and/or embryo/fetal risk. Maternal cholera disease is associated with adverse pregnancy outcomes including fetal death.

Fetal/neonatal adverse reactions: The vaccine strain may be shed in the stool of the vaccinated mother for at least 7 days, with a potential for transmission of the vaccine strain from mother to infant during vaginal delivery.

Lactation Risk Summary: Vaxchora is not absorbed systemically by the mother following oral administration, and breastfeeding is not expected to result in exposure of the child to Vaxchora .

PEDIATRIC USE: The safety and effectiveness of Vaxchora have not been established in children and adolescents younger than 18 years.

GERIATRIC USE: The safety and effectiveness of Vaxchora have not been established in adults 65 years of age or older.

IMMUNOCOMPROMISED INDIVIDUALS: The safety and effectiveness of Vaxchora have not been established in immunocompromised individuals.The immunologic response to Vaxchora may be diminished in immunocompromised individuals.

Vaccine-Related Posts:
Menhibrix Side Effects

Vaxchora Side Effects, Safety, and Effectiveness posted 5 October 2016. Last update on 5 October 2016.